abstract |
The present invention relates to a method for increasing the half-life of GM-CSF, including GM-CSF substitution for one or more lysine residues present in the amino acid sequence of GM-CSF, or GM-CSF with an increased half-life, GM-CSF remains in the human body for a long time and has excellent therapeutic effect. |